Skip to main content
logo
Sonnet BioTherapeutics Holdings, Inc. (SONN)
Dec 2, 2025 - SONN was delisted (reason: merged into PURR)
1.260
-1.840 (-59.35%)
Inactive · Last trade price on Dec 2, 2025

SONN Financials Overview

Millions USD. Fiscal year is Oct - Sep.

Revenue & Profits
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJun '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20
Revenue
10.020.150.350.48-
Revenue Growth
1689.52%-87.40%-57.76%-27.64%--
Gross Profit
-0.77-0.090.03-21.09-16.15-9.88
Operating Income
-14.06-11.85-18.79-29.67-25.09-17.41
Net Income
-13.56-7.44-18.83-29.72-24.98-65.6
Earnings Per Share
-5.01-11.35-145.13-1204.14--
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJun '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20
Cash & Investments
0.320.152.273.0527.627.35
Total Debt
0.070.130.20.260.130.35
Net Cash (Debt)
0.250.022.072.827.57
Net Cash Growth
-92.58%-99.10%-25.98%-89.83%292.99%-
Net Cash Per Share
0.090.0315.96113.31--

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJun '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20
Operating Cash Flow
-10.31-8.61-21.34-27.77-22.55-15.61
Capital Expenditures
-----0-0.08
Free Cash Flow
-10.31-8.61-21.34-27.77-22.56-15.69
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJun '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20
Gross Margin
-76.75%-17.96%---
Operating Margin
-1405.87%-63617.90%-12714.47%-8478.34%-5187.36%-
Pretax Margin
-1339.78%-39929.30%-12741.58%-8493.34%-5165.97%-
Profit Margin
-1355.62%-39929.30%-12741.58%-8493.34%-5165.97%-
FCF Margin
-1031.07%-46213.48%-14439.19%-7936.59%-4663.91%-

Valuation
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingAug '26 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20
PS Ratio
3.41233.5833.9320.5072.86-